Why Can a Good Embryo Fail to Implant?

Yes, a good-quality embryo can fail to implant. Embryo grading tells doctors how an embryo looks and how it has developed in the laboratory, but it cannot guarantee that the embryo is chromosomally normal or that implantation will occur.

Implantation is a complex biological process that requires an embryo with developmental potential to interact successfully with a receptive endometrium. Factors involving the embryo, uterus, endometrium, hormones and, in some cases, both partners can influence the outcome.

A single failed embryo transfer does not necessarily mean that there is a problem with the uterus or that future IVF treatment will fail. When implantation failure happens repeatedly, however, a structured review of the previous IVF cycles may help determine whether further assessment is appropriate. The American Society for Reproductive Medicine (ASRM) published updated guidance on recurrent implantation failure in 2026.

What Does “Good-Quality Embryo” Mean?

A good-quality embryo is an embryo that has favorable characteristics when assessed by an embryologist.

Depending on the stage of development, assessment may consider factors such as:

• Cell number and developmental stage
• Degree of fragmentation
• Blastocyst expansion
• Appearance of the inner cell mass
• Appearance of the trophectoderm
• How the embryo has developed over time

However, embryo morphology is not the same as genetic normality.

An embryo can look favorable under the microscope while carrying a chromosomal abnormality that cannot be identified through morphology alone.

This distinction is important when patients ask:

“If my embryo was good quality, why didn’t it implant?”

The answer is that appearance is only one part of embryo competence.

Why Can a Good Embryo Fail to Implant?

A good-quality embryo may fail to implant because of:

1. Chromosomal abnormalities that are not visible from embryo grading
2. Biological factors affecting embryo development or viability
3. Uterine or endometrial abnormalities
4. Factors affecting the interaction between the embryo and endometrium
5. Age-related changes in embryo chromosomal status
6. Certain tubal or pelvic conditions, such as hydrosalpinx
7. Factors that remain unexplained despite appropriate investigation

These factors do not all apply to every patient, and a failed transfer does not automatically identify one of them as the cause.

1. The Embryo May Look Good but Still Have Chromosomal Abnormalities

One of the most important reasons a good-quality embryo may fail to implant is aneuploidy, meaning an abnormal number of chromosomes.

Chromosomal abnormalities can interfere with implantation and embryo development. Age-related aneuploidy is considered an important contributor to implantation failure because aneuploid blastocysts have very limited potential for sustained implantation and live birth.

This explains why embryo grading cannot provide a guarantee.

Can a Good-Quality Embryo Be Genetically Abnormal?

Yes.

Embryo morphology and chromosomal status are different measurements.

A blastocyst may receive a favorable morphological grade while still being aneuploid. Conversely, embryo appearance alone cannot establish whether an embryo will implant.

This is also why “good-quality embryo” and “euploid embryo” should not be treated as interchangeable terms.

2. Age Can Affect Embryo Chromosomal Health

Age is an important factor in reproductive outcomes because the likelihood of chromosomal abnormalities in eggs and embryos increases with age.

This does not mean that age determines the outcome of an individual embryo transfer. It means that age is one of the factors a fertility specialist considers when assessing prognosis.

The relationship between age and embryo chromosomal status is particularly relevant when a patient has experienced unsuccessful transfers despite apparently good-quality embryos.

3. The Uterine Cavity May Affect Implantation

For an embryo to implant, the uterine environment needs to be suitable.

Structural abnormalities that may be relevant include:

• Endometrial polyps
• Submucosal fibroids
• Intrauterine adhesions
• Certain uterine abnormalities
• Hydrosalpinx
• Other conditions affecting the reproductive tract

ASRM identifies uterine cavity assessment as an important part of evaluating patients when recurrent implantation failure is suspected. Depending on the clinical situation, assessment may involve sonohysterography, hysteroscopy or three-dimensional ultrasound.

However, this does not mean that every patient with one failed embryo transfer needs hysteroscopy or extensive uterine testing.

The appropriate evaluation depends on the patient’s history and previous treatment.

4. The Endometrium Must Be Suitable for Implantation

The endometrium is the lining of the uterus where implantation occurs.

For implantation to happen, the endometrium must undergo the appropriate biological changes during the relevant implantation window.

An abnormal uterine cavity, inadequate endometrial development or certain inflammatory conditions may be relevant in selected patients.

However, the phrase “the embryo did not implant because the lining was not receptive” should not automatically be used as an explanation after a failed transfer.

Endometrial receptivity is complex, and currently available commercial receptivity tests do not have sufficient evidence to be routinely recommended for recurrent implantation failure. ASRM’s 2026 guidance specifically notes conflicting evidence regarding endometrial receptivity analysis (ERA), while a large randomized trial found no significant improvement in live-birth rate when ERA was used to guide the timing of euploid frozen embryo transfer.

5. Hydrosalpinx Can Be Relevant

A hydrosalpinx is a fallopian tube that has become distended with fluid, usually because of previous damage or inflammation.

Hydrosalpinx is one of the structural factors that may be associated with implantation problems and should be considered when clinically appropriate, particularly during evaluation of recurrent implantation failure.

This is one reason the patient’s previous fertility history and imaging findings matter when reviewing an unsuccessful embryo transfer.

6. Endometriosis or Adenomyosis May Be Relevant in Selected Patients

Endometriosis and adenomyosis can be associated with infertility and may be considered when assessing repeated unsuccessful treatment.

However, they should not automatically be identified as the cause of a single failed embryo transfer.

ASRM’s current recurrent implantation failure guidance notes that hormonal suppression strategies for endometriosis or adenomyosis may be considered in selected patients, but evidence for improving live-birth rates remains inconclusive and these approaches cannot be routinely recommended for recurrent implantation failure.

The appropriate approach depends on the patient’s symptoms, diagnosis, previous treatment and reproductive goals.

7. Fertilization and Embryo Development Are Different From Implantation

A successful embryo transfer means that the embryo reached the transfer stage. It does not mean that implantation is guaranteed.

IVF involves several biological stages:

Egg retrieval → fertilization → embryo development → embryo selection → embryo transfer → implantation → early pregnancy

An embryo can successfully reach the blastocyst stage and still fail to implant.

This distinction is important because the reason for a failed cycle may become clearer when the complete treatment history is reviewed rather than focusing only on the final embryo transfer.

8. What If the Embryo Was Euploid?

A euploid embryo has the expected number of chromosomes based on the genetic test performed.

Even a euploid embryo can fail to implant.

A euploid result reduces one important source of uncertainty, but it does not guarantee implantation or live birth. Implantation still depends on complex interactions between the embryo and the reproductive environment.

ASRM’s 2026 guidance notes that there is currently no evidence that PGT-A increases live-birth rates specifically in patients with recurrent implantation failure. PGT-A may be considered in selected patients using shared decision-making, but it should not be presented as a guaranteed solution to implantation failure.

9. Sperm Factors Are Not Always the Explanation

Male-factor infertility can influence fertilization and embryo development, but patients should be cautious about assuming that sperm factors explain every failed embryo transfer.

Semen analysis evaluates characteristics such as sperm concentration, motility and morphology. Other sperm characteristics can be investigated in selected situations.

However, ASRM’s 2026 recurrent implantation failure guidance states that there is insufficient evidence to routinely recommend sperm DNA fragmentation testing specifically for recurrent implantation failure.

This is an important example of why additional testing should be based on the clinical situation rather than automatically added after an unsuccessful transfer.

10. Sometimes There Is No Single Identifiable Cause

This can be difficult for patients to hear, but it is medically important.

Even after reviewing embryo development, the uterine cavity, the endometrium and relevant medical history, doctors may not be able to identify one definite reason why implantation did not occur.

That does not mean that something was necessarily done incorrectly.

It also does not mean that another embryo cannot implant successfully.

ASRM states that when no clear, correctable cause is identified after a detailed review of the patient’s history and IVF cycles, extensive additional testing is not necessarily appropriate. Further embryo transfer procedures may remain reasonable because many patients will ultimately achieve pregnancy.

Does One Failed Embryo Transfer Mean I Have Implantation Failure?

No. One failed embryo transfer does not automatically mean recurrent implantation failure.

Recurrent implantation failure is a specific clinical situation involving repeated unsuccessful implantation, and definitions have varied considerably.

In its 2026 committee opinion, ASRM recommends defining recurrent implantation failure according to failure of the estimated number of good-quality blastocysts required to reach a 95% cumulative probability of a positive pregnancy test, taking factors such as embryo ploidy and patient characteristics into account.

This means that the number of previous transfers, embryo stage, whether embryos were genetically tested and the patient’s age all matter.

What Should Be Reviewed After a Failed Embryo Transfer?

The next step should not automatically be another IVF cycle or a long list of additional tests.

A fertility specialist may first review:

The embryo

• Was it a cleavage-stage embryo or blastocyst?
• What was its morphological grade?
• Was genetic testing performed?
• Were other embryos available from the same cycle?
• Did other embryos stop developing earlier?

The IVF cycle

• How many eggs were retrieved?
• How many were mature?
• How did fertilization proceed?
• How many embryos developed?
• Were embryos frozen for future treatment?

The uterus and endometrium

• Has the uterine cavity been assessed?
• Are there known fibroids, polyps or adhesions?
• Is there evidence of hydrosalpinx?
• Are there relevant endometrial findings?
• Is further assessment clinically justified?

Previous treatment history

• How many embryo transfers have occurred?
• Were they fresh or frozen transfers?
• Were the embryos tested?
• Was implantation followed by an early pregnancy loss rather than complete implantation failure?

These distinctions can significantly change how the next step is approached.

Should I Have More Tests After a Failed Embryo Transfer?

Not necessarily.

More testing is not automatically better treatment.

When recurrent implantation failure is suspected, ASRM recommends targeted assessment based on the patient’s history and previous IVF cycles. Possible areas of evaluation include structural uterine factors and selected genetic or inflammatory factors.

At the same time, ASRM does not currently recommend routine use of several proposed interventions or tests for recurrent implantation failure, including:

• Sperm DNA fragmentation testing specifically for RIF
• Endometrial receptivity panels
• BCL-6 testing
• Endometrial scratching
• Routine immune therapies such as IVIG
• Routine anticoagulation without an appropriate indication

The evidence for these approaches is insufficient or does not demonstrate improved live-birth outcomes in the RIF population.

This is why an individualized assessment is more useful than automatically ordering every available fertility test.

Can Another Embryo Implant After a Failed Transfer?

Yes. A previous failed embryo transfer does not mean that another embryo will necessarily fail to implant.

The outcome of another transfer depends on multiple factors, including:

• Age
• Embryo characteristics
• Embryo chromosomal status when known
• Uterine anatomy
• Endometrial factors
• Fertility diagnosis
• Previous treatment history
• Other individual clinical factors

If suitable frozen embryos remain, another embryo transfer may be possible without repeating ovarian stimulation and egg retrieval. HFEA notes that frozen embryos can be used in future treatment if the first IVF cycle is unsuccessful.

Dr. Emad Darwish provides embryo freezing as part of his fertility and IVF services. Embryo freezing allows suitable embryos created during IVF to be preserved for future treatment.

What Is the Difference Between Embryo Quality and Implantation Potential?

These terms are related but not identical.

This distinction is one of the most important things to understand after an unsuccessful embryo transfer.

A good-quality embryo is a favorable finding, not a guarantee of pregnancy.

When Should Repeated Implantation Failure Be Investigated?

A specialist assessment becomes particularly relevant when unsuccessful embryo transfers occur repeatedly, especially when good-quality or euploid embryos have been transferred without implantation.

The purpose of the evaluation is not simply to order more tests. It is to determine whether there is a clinically meaningful factor that can be identified or treated.

Dr. Emad Darwish’s fertility services include recurrent IVF failure treatment, with reassessment of previous treatment and development of an individualized strategy. His practice also provides pre-IVF assessment and fertility testing to evaluate factors relevant to fertility treatment. Fertility and IVF services

Why Individual Assessment Matters

There is no single treatment that guarantees implantation after a failed embryo transfer.

Two patients may both have a good-quality embryo that fails to implant but require completely different approaches.

One may have no identifiable problem and may reasonably proceed with another transfer. Another may need assessment of the uterine cavity because of a suspected structural issue. A different patient may need a broader review of embryo development, age-related factors or previous IVF outcomes.

The objective is to identify what is relevant to the individual patient, rather than assuming that every unsuccessful transfer has the same explanation.

Dr. Emad Darwish is a Consultant in Obstetrics and Gynecology and Consultant in Reproductive Medicine and IVF. His website states that he has more than 16 years of clinical and academic experience in infertility treatment, IVF and assisted reproductive medicine and provides personalized treatment planning based on the patient’s condition. About Dr. Emad Darwish

If you have experienced a failed embryo transfer, a consultation can help review the previous IVF cycle, identify which factors may warrant further assessment and determine whether another transfer or a different treatment strategy is appropriate.

Book an appointment with Dr. Emad Darwish to discuss your previous treatment and possible next steps.

Medical disclaimer: This content is intended for general educational purposes and does not replace individualized medical assessment. Fertility treatment recommendations depend on medical history, test results, age, reproductive goals and other individual factors.

FAQ

Can a good-quality embryo fail to implant?

Yes. A good-quality embryo can fail to implant because embryo morphology does not guarantee chromosomal normality or successful implantation. Uterine, endometrial and other biological factors can also contribute.

Why does a good embryo fail to implant after IVF?

Possible reasons include chromosomal abnormalities, uterine or endometrial factors, hydrosalpinx, age-related embryo factors and other biological factors. Sometimes no single cause can be identified.

Can a euploid embryo fail to implant?

Yes. A euploid embryo has the expected chromosome number based on the genetic test performed, but euploid status does not guarantee implantation or live birth.

Does one failed embryo transfer mean I have recurrent implantation failure?

No. One unsuccessful embryo transfer does not automatically constitute recurrent implantation failure. Current ASRM guidance uses a more individualized definition based on the number and characteristics of embryos transferred and the cumulative probability of implantation.

Should I have a hysteroscopy after a failed embryo transfer?

Not automatically. Hysteroscopy or other uterine-cavity assessment may be appropriate when recurrent implantation failure is suspected or when the patient’s history suggests a structural problem.

Does endometrial receptivity testing improve implantation?

Current evidence does not support routine use of endometrial receptivity testing for recurrent implantation failure. A large randomized trial found no significant improvement in live-birth rate when ERA was used to guide the timing of euploid frozen embryo transfer.

Can another embryo implant after one failed transfer?

Yes. A previous failed transfer does not mean that another embryo will necessarily fail. The appropriate next step depends on the patient’s individual reproductive history and treatment findings.

What should I do after a failed embryo transfer?

The first step is usually to review the previous IVF cycle, including embryo development, embryo characteristics, transfer details, uterine assessment and relevant medical history. Additional testing should be targeted rather than automatically performed.